Concepedia

Geoffrey Y. Ku

GY

85

Publications

9.2K

Citations

34

H-Index

1977

Active since

Affiliations

Memorial Sloan Kettering Cancer Center(Current)

Cornell University

The University of Texas MD Anderson Cancer Center

Molecular Oncology (United States)

University of Chicago

Geoffrey Y. Ku is an author at Memorial Sloan Kettering Cancer Center specializing in medicine, oncology, and radiation oncology.

Top concepts

MedicineOncologyRadiation OncologyCancer ResearchPathologyCancer TherapyGastroenterologyImmunologyMolecular OncologySurgery

Publications per year

1977–2025

85

Publications

85

Tumor mutational load predicts survival after immunotherapy across multiple cancer types

Robert Samstein, Chung‐Han Lee, Alexander N. Shoushtari et al. · Nature Genetics · 2019 · 4.2K citations · Full text

Cancer Immunosurveillance, Tumor Heterogeneity, Medicine +9

Preoperative CTLA-4 Blockade: Tolerability and Immune Monitoring in the Setting of a Presurgical Clinical Trial

Bradley Curtis Carthon, Jedd D. Wolchok, Jianda Yuan et al. · Clinical Cancer Research · 2010 · 456 citations · Full text

Single‐institution experience with ipilimumab in advanced melanoma patients in the compassionate use setting

Geoffrey Y. Ku, Jianda Yuan, David B. Page et al. · Cancer · 2010 · 420 citations · Full text

Genetic Predictors of Response to Systemic Therapy in Esophagogastric Cancer

Yelena Y. Janjigian, Francisco Sánchez-Vega, Philip Jonsson et al. · Cancer Discovery · 2017 · 373 citations · Full text

First-line pembrolizumab and trastuzumab in HER2-positive oesophageal, gastric, or gastro-oesophageal junction cancer: an open-label, single-arm, phase 2 trial

Yelena Y. Janjigian, Steven B. Maron, Walid K. Chatila et al. · The Lancet Oncology · 2020 · 347 citations · Full text

First-line Pembrolizumab, Esophageal Cancer, Gastrointestinal Oncology +7

Rows per page

1–5 of 85